271 related articles for article (PubMed ID: 2317795)
1. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
Wadler S; Goldman M; Lyver A; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
[TBL] [Abstract][Full Text] [Related]
2. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
Wadler S; Schwartz EL; Goldman M; Lyver A; Rader M; Zimmerman M; Itri L; Weinberg V; Wiernik PH
J Clin Oncol; 1989 Dec; 7(12):1769-75. PubMed ID: 2585018
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
[TBL] [Abstract][Full Text] [Related]
4. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
Wadler S; Wiernik PH
Semin Oncol; 1990 Feb; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.
Wadler S; Lembersky B; Atkins M; Kirkwood J; Petrelli N
J Clin Oncol; 1991 Oct; 9(10):1806-10. PubMed ID: 1919631
[TBL] [Abstract][Full Text] [Related]
7. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil and recombinant alpha interferon-2a in the treatment of advanced colorectal carcinoma: a dose optimization study.
Palmeri S; Gebbia V; Rausa L
J Chemother; 1990 Oct; 2(5):327-30. PubMed ID: 2090772
[TBL] [Abstract][Full Text] [Related]
9. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
Wadler S; Damle S; Haynes H; Kaleya R; Schechner R; Berkenblit R; Ladner RD; Murgo A
J Clin Oncol; 1999 Jun; 17(6):1771-8. PubMed ID: 10561214
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
Pazdur R; Ajani JA; Patt YZ; Winn R; Jackson D; Shepard B; DuBrow R; Campos L; Quaraishi M; Faintuch J
J Clin Oncol; 1990 Dec; 8(12):2027-31. PubMed ID: 2230894
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
[TBL] [Abstract][Full Text] [Related]
12. Clinical toxicities of the combination of 5-fluorouracil and recombinant interferon alfa-2a: an unusual toxicity profile.
Wadler S; Lyver A; Wiernik PH
Oncol Nurs Forum; 1989; 16(6 Suppl):12-5. PubMed ID: 2594551
[TBL] [Abstract][Full Text] [Related]
13. Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.
Danhauser LL; Freimann JH; Gilchrist TL; Gutterman JU; Hunter CY; Yeomans AC; Markowitz AB
J Clin Oncol; 1993 Apr; 11(4):751-61. PubMed ID: 8478667
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.
Pazdur R; Ajani JA; Winn R; Bearden J; Belt RJ; Pilat S; Hallinan R; Levin B
Cancer; 1992 Feb; 69(4):878-82. PubMed ID: 1735078
[TBL] [Abstract][Full Text] [Related]
15. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
Kemeny N; Younes A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.
Budd GT; Murthy S; Finke J; Sergi J; Gibson V; Medendorp S; Barna B; Boyett J; Bukowski RM
J Clin Oncol; 1992 May; 10(5):804-9. PubMed ID: 1569452
[TBL] [Abstract][Full Text] [Related]
18. Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trial.
Pazdur R; Moore DF; Bready B
Semin Oncol; 1992 Apr; 19(2 Suppl 3):176-9. PubMed ID: 1557643
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasms.
Pazdur R
Br J Haematol; 1991 Oct; 79 Suppl 1():56-9. PubMed ID: 1931711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
